The impact of lidocaine plaster prescribing reduction strategies: A comparison of two national health services in Europe.
clinical pharmacology
drug regulation
health policy
prescribing
Journal
British journal of clinical pharmacology
ISSN: 1365-2125
Titre abrégé: Br J Clin Pharmacol
Pays: England
ID NLM: 7503323
Informations de publication
Date de publication:
08 2023
08 2023
Historique:
revised:
26
04
2023
received:
07
03
2023
accepted:
03
05
2023
medline:
21
7
2023
pubmed:
11
5
2023
entrez:
10
5
2023
Statut:
ppublish
Résumé
In 2017, two distinct interventions were implemented in Ireland and England to reduce prescribing of lidocaine medicated plasters. In Ireland, restrictions on reimbursement were introduced through implementation of an application system for reimbursement. In England, updated guidance on items which should not be routinely prescribed in primary care, including lidocaine plasters, was published. This study aims to compare how the interventions impacted prescribing of lidocaine plasters in these countries. We conducted an interrupted time-series study using general practice data. For Ireland, monthly dispensing data (2015-2019) from the means-tested General Medical Services (GMS) scheme was used. For England, data covered all patients. Outcomes were the rate of dispensings, quantity and costs of lidocaine plasters, and we modelled level and trend changes from the first full month of the policy/guidance change. Ireland had higher rates of lidocaine dispensings compared to England throughout the study period; this was 15.22/1000 population immediately pre-intervention, and there was equivalent to a 97.2% immediate reduction following the intervention. In England, the immediate pre-intervention dispensing rate was 0.36/1000, with an immediate reduction of 0.0251/1000 (a 5.8% decrease), followed by a small but significant decrease in the monthly trend relative to the pre-intervention trend of 0.0057 per month. Among two different interventions aiming to decrease low-value lidocaine plaster prescribing, there was a substantially larger impact in Ireland of reimbursement restriction compared to issuing guidance in England. However, this is in the context of much higher baseline rates of use in Ireland compared to England.
Substances chimiques
Lidocaine
98PI200987
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2349-2358Informations de copyright
© 2023 The Authors. British Journal of Clinical Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society.
Références
WHO. The world health report: health systems financing: the path to universal coverage. 2010. Accessed May 16, 2023. https://apps.who.int/iris/handle/10665/44371
OECD. Health at a glance 2021: OECD Indicators. 2021. doi:10.1787/ae3016b9-en
WHO. The rational use of drugs: review of major issues. 1985. Accessed May 16, 2023. https://apps.who.int/iris/handle/10665/62311
WHO. Promoting rational use of medicines. Accessed May 16, 2023. https://www.who.int/activities/promoting-rational-use-of-medicines/
Radomski TR, Decker A, Khodyakov D, et al. Development of a metric to detect and decrease low-value prescribing in older adults. JAMA Netw Open. 2022;5(2):e2148599. doi:10.1001/jamanetworkopen.2021.48599
Management Sciences for Health. MDS-3: Managing Access to Medicines and Health Technologies. Management Sciences for Health; 2012.
HSE. Medicine Management Health Service Executive. Accessed May 16, 2023. https://www.hse.ie/eng/about/who/cspd/ncps/medicines-management/
Medicines Management Programme. Lidocaine 700 mg Medicated Plaster (Versatis®)-Prescribing and Cost Guidance. Medicines Management Programme; 2021.
NHS England. NHS England to issue new guidance on low value prescription items. Updated March 28, 2017. Accessed February 2, 2023. https://www.england.nhs.uk/2017/03/guidance-on-low-value-prescription-items/
NHS Clinical Commissioners. Items which should not routinely be prescribed in primary care: guidance for CCGs. 2nd ed. NHS England; 2019.
Wagner AK, Soumerai SB, Zhang F, Ross-Degnan D. Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther. 2002;27(4):299-309. doi:10.1046/j.1365-2710.2002.00430.x
Cuschieri S. The STROBE guidelines. Saudi J Anaesth. 2019;13(Suppl 1):S31-S34. doi:10.4103/sja.SJA_543_18
Mattsson M, Flood M, Wallace E, Boland F, Moriarty F. Eligibility rates and representativeness of the General Medical Services scheme population in Ireland 2017-2021: a methodological report [version 1; peer review: awaiting peer review]. HRB Open Res. 2022;5:67. doi:10.12688/hrbopenres.13622.1
Sinnott SJ, Bennett K, Cahir C. Pharmacoepidemiology resources in Ireland-an introduction to pharmacy claims data. Eur J Clin Pharmacol. 2017;73(11):1449-1455. doi:10.1007/s00228-017-2310-7
NHS. Prescribing data. Accessed May 16, 2023. https://digital.nhs.uk/data-and-information/areas-of-interest/prescribing
Linden A. XTITSA: Stata module for performing interrupted time-series analysis for panel data. Statistical Software Components. 2021. https://ideas.repec.org/s/boc/bocode.html
Park Y, Raza S, George A, Agrawal R, Ko J. The effect of formulary restrictions on patient and payer outcomes: a systematic literature review. J Manag Care Spec Pharm. 2017;23(8):893-901. doi:10.18553/jmcp.2017.23.8.893
Moore RA. What works for whom? Determining the efficacy and harm of treatments for pain. Pain. 2013;154(Supplement 1):S77-S86. doi:10.1016/j.pain.2013.03.024
Mattsson M, Boland F, Kirke C, et al. Evaluation of policies and practices to support safe and appropriate analgesic and sedative prescribing: the CDRx (controlled drug prescribing) protocol. Res Social Adm Pharm. 2022;18(9):3588-3595. doi:10.1016/j.sapharm.2022.03.004
Maratt JK, Kerr EA, Klamerus ML, et al. Measures used to assess the impact of interventions to reduce low-value care: a systematic review. J Gen Intern Med. 2019;34(9):1857-1864. doi:10.1007/s11606-019-05069-5
Walker AJ, Curtis HJ, Bacon S, Croker R, Goldacre B. Trends and variation in prescribing of low-priority treatments identified by NHS England: a cross-sectional study and interactive data tool in English primary care. J R Soc Med. 2018;111(6):203-213. doi:10.1177/0141076818769408
Walker AJ, Bacon S, Curtis H, Croker R, MacKenna B, Goldacre B. Six months on: NHS England needs to focus on dissemination, implementation and audit of its low-priority initiative. J R Soc Med. 2018;112(1):4-5. doi:10.1177/0141076818808429
Croker R, Walker AJ, Goldacre B. Why did some practices not implement new antibiotic prescribing guidelines on urinary tract infection? A cohort study and survey in NHS England primary care. J Antimicrob Chemother. 2019;74(4):1125-1132. doi:10.1093/jac/dky509
Smith A, Doran S, Daly M, Kennedy C, Barry M. Effect of an online reimbursement application system on prescribing of lidocaine 5% medicated plaster in the Republic of Ireland. Appl Health Econ Health Policy. 2021;19(1):133-140. doi:10.1007/s40258-020-00586-5
Lau R, Stevenson F, Ong BN, et al. Achieving change in primary care-causes of the evidence to practice gap: systematic reviews of reviews. Implement Sci. 2016;11(1):40. doi:10.1186/s13012-016-0396-4
Ingvarsson S, Hasson H, von Thiele Schwarz U, et al. Strategies for de-implementation of low-value care-a scoping review. Implement Sci. 2022;17(1):73. doi:10.1186/s13012-022-01247-y
Patel KV, Guralnik JM, Dansie EJ, Turk DC. Prevalence and impact of pain among older adults in the United States: findings from the 2011 National Health and Aging Trends Study. Pain. 2013;154(12):2649-2657. doi:10.1016/j.pain.2013.07.029
Leveille SG, Jones RN, Kiely DK, et al. Chronic musculoskeletal pain and the occurrence of falls in an older population. JAMA. 2009;302(20):2214-2221. doi:10.1001/jama.2009.1738
Janevic MR, McLaughlin SJ, Heapy AA, Thacker C, Piette JD. Racial and socioeconomic disparities in disabling chronic pain: findings from the Health and Retirement Study. J Pain. 2017;18(12):1459-1467. doi:10.1016/j.jpain.2017.07.005
Mills SEE, Nicolson KP, Smith BH. Chronic pain: a review of its epidemiology and associated factors in population-based studies. Br J Anaesth. 2019;123(2):e273-e283. doi:10.1016/j.bja.2019.03.023
Chiedozie C, Murphy ME, Fahey T, Moriarty F. How many medications do doctors in primary care use? An observational study of the DU90% indicator in primary care in England. BMJ Open. 2021;11(3):e043049. doi:10.1136/bmjopen-2020-043049
Tian J, McGrogan A, Jones MD. Temporal and geographical variation in low carbon inhaler dispensing in England, 2016 to 2021: an ecological study. J R Soc Med. 2023;116(2):65-75. doi:10.1177/01410768221133566
Edelstein M, Agbebiyi A, Ashiru-Oredope D, Hopkins S. Trends and patterns in antibiotic prescribing among out-of-hours primary care providers in England, 2010-14. J Antimicrob Chemother. 2017;72(12):3490-3495. doi:10.1093/jac/dkx323
MacKenna B, Curtis HJ, Walker AJ, Bacon S, Croker R, Goldacre B. Suboptimal prescribing behaviour associated with clinical software design features: a retrospective cohort study in English NHS primary care. Br J Gen Pract. 2020;70(698):e636-e643. doi:10.3399/bjgp20X712313
Curtis HJ, Bacon S, Croker R, et al. Evaluating the impact of a very low-cost intervention to increase practices' engagement with data and change prescribing behaviour: a randomized trial in English primary care. Fam Pract. 2021;38(4):373-380. doi:10.1093/fampra/cmaa128
Walker AJ, Curtis HJ, Croker R, Bacon S, Goldacre B. Measuring the impact of an open web-based prescribing data analysis service on clinical practice: cohort study on NHS England data. J Med Internet Res. 2019;21(1):e10929. doi:10.2196/10929
Ivers N, Jamtvedt G, Flottorp S, et al. Audit and feedback: effects on professional practice and healthcare outcomes. Cochrane Database Syst Rev. 2012;(6):Cd000259. doi:10.1002/14651858.CD000259.pub3
Ashworth M, Armstrong D, Lloyd D, Colwill S. The effects on GP prescribing of joining a commissioning group. J Clin Pharm Ther. 2002;27(3):221-228. doi:10.1046/j.1365-2710.2002.00414.x
Government of Ireland. Sláintecare implementation strategy. 2018. Published August 7, 2018. Updated October 26, 2020. Accessed May 16, 2023. https://www.gov.ie/en/publication/6011cf-slaintecare-implementation-strategy/